Sign in to view content

A 10-Year Follow-up on Outcomes of Intravitreal Anti-VEGF Injections for Choroidal Neovascularization Secondary to Ocular Histoplasmosis

Carl Noble, DO, MBA

Video
Published 2021

Related

Comparing Rates of Vitrectomy in Proliferative Diabetic Retinopathy Patients Treated With Anti-VEGF or Panretinal Photocoagulation Monotherapy
Nadim M Rayess, MD
Annual Meeting Talks
2021
The Impact of the COVID-19 Pandemic on Aflibercept and Ranibizumab Anti-VEGF Injections
Kapil Mishra, MD
On Demand Cases, Courses, and Papers
2021
Baseline Factors Associated With 1-Year Outcomes in Phase III Comparison of SB11 (Approved Ranibizumab Biosimilar) With Reference Ranibizumab in nAMD
Neil M. Bressler, MD
Annual Meeting Talks
2022

Category: Inflammatory and Infectious Diseases

See more